← State of Embedded Finance 2026

Dna Services

Insufficient evidence to determine strategic thesis.

IndustryVertical SaaS / Healthcare
The story

Insufficient evidence to construct a pivot narrative for DNA Services. The evidence provided largely relates to unrelated companies (DNAnexus, DNA Payments, MyHeritage, 23andMe, Ancestry.com) and generic vendor marketing pages. No authoritative company history for a company named 'DNA Services' was found.

Last 12 months
The stack
Accounting gap: none